SCHEMBL27793545

SCHEMBL27793545

C[CH]c1ccc(F)c(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
VCP P55072 1/20 0.50
MAOB P27338 5/20 0.43
MAOA P21397 4/20 0.43
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NFE2L2 Q16236 2/20 0.36
NPSR1 Q6W5P4 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TRPA1 O75762 2/20 0.32
ALDH1A1 P00352 1/20 0.32
ALDH1A3 P47895 1/20 0.32
MGAM O43451 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2660226 0.83 VCP (0.56) VCPMAOBMAOANPC1RAB9A
SCHEMBL2660229 0.83 VCP (0.56) VCPMAOBMAOANPC1RAB9A
SCHEMBL28239186 0.82 KDM1A (0.37) VCPNFE2L2TRPA1ALDH1A1MGAM
SCHEMBL4798296 0.78 NPFFR1 (0.44) NPC1TRPA1ALDH1A1ALDH1A3
SCHEMBL1547756 0.78 NFE2L2 (0.56) NPC1RAB9ANFE2L2CYP1A2TRPA1
SCHEMBL5674421 0.77 VCP (0.50) VCPMAOBMAOANPC1RAB9A
SCHEMBL11127611 0.77 VCP (0.50) VCPMAOBMAOANPC1RAB9A
SCHEMBL4065139 0.77 VCP (0.50) VCPMAOBMAOANPC1RAB9A
SCHEMBL154905 0.77 VCP (0.55) VCPMAOBMAOANPC1RAB9A
SCHEMBL29527566 0.77 VCP (0.55) VCPMAOBMAOANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103347864-B Pyrimidone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA 2 葛兰素集团有限公司 2016-08-10 CN disclosed
CN-103347864-A For treating diseases caused by Lp-PLA2Pyrimidone compounds for mediated diseases or conditions GLAXO GROUP LTD 2013-10-09 CN disclosed
CN-101855215-A For preparing 5-haloalkyl-4 DU PONT 2010-10-06 CN disclosed